Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

They're FDA approved, have the best in class treatment, and is more affordable than the others.

$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE

$KALA up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 & $TGTX is up 13% continued momentum following MS drug approvals.

i don’t know any retail that would buy 545k shares… this one actually has news like real lets make money news unlike all these other application garbage pr from shitty bios

Our best in class drug is FDA APPROVED.

$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

Great FDA approval news in a growing MS market with a need.

$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions

Guys from the fda that really know their stuff.

He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.

That means Rett NDA sections common with the Alzheimer's NDA sections will be completed simultaneously, which is good for the Alzheimers NDA. 3.

“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !

They would be able to provide medical writing, copy editing, and creative support (the latter for making figures) to the authors to expedite manuscript development and submission.

The FDA and global agencies find great comfort in NDAs accompanied by a peer review.

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

With all the scrutiny with on the FDA they will definitely be forced to approve Anavex which is the safest, cheapest on Healthcare and the patients, and most convenient drug.

$ARDX I am thrilled that the chairwoman of our Adcom gave monotherapy a thumbs up.

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

Better than money in the bank with soon resubmission and approval 2-6 months later!

So glad that I bought before ADCOM meeting.

$ARDX very good fda news on this conference call

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$AKBA within 3 to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.